trifluoperazine

Trifluoperazine is an antipsychotic medication belonging to the phenothiazine class. It is primarily used to manage psychotic disorders such as schizophrenia and other conditions characterized by psychosis, which can include hallucinations and delusions. It is also sometimes prescribed for short-term treatment of anxiety and agitation, though this is a less common use.

The mechanism of action of trifluoperazine involves blocking dopamine receptors in the brain, particularly dopamine D2 receptors. Dopamine is a neurotransmitter believed to play a significant role in the development of psychotic symptoms. By reducing dopamine activity, trifluoperazine can help to alleviate these symptoms. It also affects other neurotransmitter systems, including serotonin and norepinephrine, which may contribute to its overall therapeutic effects and side effect profile.

Trifluoperazine is typically administered orally in tablet form. The dosage and duration of treatment are determined by a healthcare professional based on the individual's condition and response to the medication. Like other antipsychotics, trifluoperazine can cause side effects, which may include drowsiness, dizziness, dry mouth, blurred vision, and movement disorders such as tardive dyskinesia, which can be irreversible. It is important for patients to discuss any potential side effects with their doctor. The medication should be used cautiously in individuals with certain medical conditions, and potential drug interactions should be carefully considered.